PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Digoxin - Arrhythmias
PAD Profile : Digoxin - Arrhythmias
Keywords :
atrial fibrillation, atrial flutter, cardiac glycosides
Brand Names Include :
Lanoxin
Traffic Light Status
Status 1 of 2.
Status :
Green
Important
Formulations :
- Elixir
- Tablets
Important Information :
ONE 62.5mcg tablet is equivalent to 50mcg (1ml) of elixir
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Amiodarone hydrochloride
- Flecainide acetate
- Propafenone hydrochloride
- Sotalol hydrochloride
- Atenolol
- Mexiletine hydrochloride
- Bisoprolol fumarate
- Disopyramide
- Esmolol hydrochloride
- Lidocaine
- Metoprolol tartrate
- Procainamide hydrochloride
- Propranolol hydrochloride
- Verapamil hydrochloride
Other Indications
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 September 2020
Guidelines (Local)
01 September 2020
Committee Recommendations
Date
Committee Name
Narrative
06 December 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Updated Kent Surrey & Sussex Academic Health Science Network (KSS AHSN) Atrial Fibrillation pathways attached for information (See below)
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status.
Associated BNF Codes
02. Cardiovascular System
02.01.01. Cardiac glycosides